Sign in to fuzzto save your conversations, follow your research and come back anytime.
In the news

Sudarshan Pharma under due diligence for 9.50% MedTherapy stake

Sudarshan Pharma hits 5% upper circuit on MedTherapy Biotech stake

Sudarshan Pharma jumps 2.8% on GMP certifications amid market crash

Sudarshan Pharma hits upper circuit for third straight session

Sudarshan Pharma hits 10% upper circuit despite market crash

Sudarshan Pharma surges 4% on Q3FY26 results